Brief: PhoenixBio to acquire Canada-based firm KMT Hepatech for C$5.5 mln
14/11/2017 08:13
Nov 14 (Reuters) - PhoenixBio Co Ltd 6190.T
* Says it plans to fully acquire Canada-based firm KMT
Hepatech,Inc in December via SPC, at the price of C$5.5 million
Source text in Japanese: https://goo.gl/6sSAoF
Further company coverage: 6190.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))